BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
kidney wet weight |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
kidney mass |
male |
132 days-146 days |
21 |
1.17 |
g |
0.04 |
0.2 |
post excision weight measurement |
|
|
0 |
ng/kg/min |
|
11546 |
101 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
single kidney wet weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
kidney mass |
male |
132 days-146 days |
21 |
3.8 |
g/kg |
0.09 |
0.4 |
post excision weight measurement |
|
|
0 |
ng/kg/min |
kidney wet weight to body weight ratio (CMO:0003389) |
11547 |
101 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
body weight |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
body mass |
male |
132 days-146 days |
21 |
315.2 |
g |
5.24 |
24.0 |
body weighing method |
|
|
0 |
|
|
11548 |
101 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
heart left ventricle wet weight |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
21 |
1.15 |
g |
0.04 |
0.2 |
post excision weight measurement |
|
0.0 |
0 |
ng/kg/min |
|
68332 |
101 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
change in heart rate to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
132 days-146 days |
11 |
-1.25 |
(beats/min)/(ug/kg) |
0.05 |
0.17 |
vascular indwelling catheter method |
|
0.0 |
0 |
ng/kg/min |
change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) |
138469 |
101 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
change in mean arterial blood pressure to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
arterial blood pressure trait |
male |
130 days-144 days |
11 |
0.71 |
mmHg/ng/kg/min |
0.02 |
0.07 |
vascular indwelling catheter method |
left femoral artery and vein |
0.0 |
0 |
microrenathane catheter; recover for 1 week after surgery |
slope of map response curve |
68342 |
101 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
heart left ventricle weight to body weight ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart left ventricle mass |
male |
132 days-146 days |
21 |
3.7 |
mg/g |
0.07 |
0.3 |
post excision weight measurement |
|
0.0 |
0 |
ng/kg/min |
Original CMO ID was CMO:0000540. Corrected 2-15-2018. |
68337 |
101 |